Eventide Asset Management - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q1 2021$1,300,000
-63.6%
960,000
-62.6%
0.02%
-65.5%
Q4 2020$3,570,000
+20.5%
2,569,000
+20.1%
0.06%
-5.2%
Q3 2020$2,963,000
+63.0%
2,139,000
+96.8%
0.06%
+45.0%
Q2 2020$1,818,000
+30.0%
1,087,0000.0%0.04%
-11.1%
Q1 2020$1,398,000
-30.0%
1,087,000
-16.4%
0.04%
-19.6%
Q4 2019$1,997,000
+45.6%
1,300,000
+30.0%
0.06%
+24.4%
Q3 2019$1,372,0001,000,0000.04%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ayrton Capital LLC 4,000,000$5,264,0006.84%
TENOR CAPITAL MANAGEMENT Co., L.P. 45,447,000$60,277,0001.18%
CSS LLC/IL 21,651,000$28,506,0001.03%
SHENKMAN CAPITAL MANAGEMENT INC 4,166,000$5,528,0000.70%
Weiss Asset Management LP 24,175,000$31,790,0000.66%
MACKAY SHIELDS LLC 36,316,000$47,889,0000.42%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 15,000,000$19,650,0000.25%
MIZUHO SECURITIES USA LLC 1,042,000$1,366,0000.20%
WOLVERINE ASSET MANAGEMENT LLC 13,230,000$17,384,0000.17%
D. E. Shaw & Co., Inc. 38,635,000$50,796,0000.05%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders